These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 2715496)
1. [L-DOPA interaction with the brain tissue DNA of rats]. Tret'iak TM; Biriukov VN; Smol'ianinova TI Izv Akad Nauk SSSR Biol; 1989; (1):64-9. PubMed ID: 2715496 [TBL] [Abstract][Full Text] [Related]
2. [Effect of L-dihydroxyphenylalanine on rat behavior and on catecholamine metabolism of the brain in rats with different degrees of emotional-behavioral reactivity]. Bondarenko NA; Miroshnichenko II; Kudrin VS; Bondarenko NA Biull Eksp Biol Med; 1988 Aug; 106(8):168-70. PubMed ID: 3416051 [TBL] [Abstract][Full Text] [Related]
3. 3-O-methyldopa blocks dopa metabolism in rat corpus striatum. Reches A; Fahn S Ann Neurol; 1982 Sep; 12(3):267-71. PubMed ID: 7137962 [TBL] [Abstract][Full Text] [Related]
4. Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration. Pérez V; Sosti V; Rubio A; Barbanoj M; Rodríguez-Alvarez J; Kulisevsky J Eur J Pharmacol; 2007 Dec; 576(1-3):83-90. PubMed ID: 17888901 [TBL] [Abstract][Full Text] [Related]
5. Effect of acute ethanol administration on brain levels of tetrahydropapaveroline in L-dopa-treated rats. Cashaw JL; Geraghty CA; McLaughlin BR; Davis VE J Neurosci Res; 1987; 18(3):497-503. PubMed ID: 3125342 [TBL] [Abstract][Full Text] [Related]
6. The novel adenosine A2a antagonist ST1535 potentiates the effects of a threshold dose of l-dopa in unilaterally 6-OHDA-lesioned rats. Rose S; Ramsay Croft N; Jenner P Brain Res; 2007 Feb; 1133(1):110-4. PubMed ID: 17196564 [TBL] [Abstract][Full Text] [Related]
7. [Characteristics of the complex formation of L-DOPA with chromatin elements from brain cells]. Arkhipova LV; Tret'iak TM Biokhimiia; 1987 Oct; 52(10):1632-6. PubMed ID: 3427130 [TBL] [Abstract][Full Text] [Related]
8. [The effect of L-DOPA on the accumulation of lipid peroxidation products in separate brain structures during irradiation]. Babaev RA; Kocharli RKh; Akhmedova GSh; Gasanova AA; Babaev KhF Radiobiologiia; 1990; 30(1):57-61. PubMed ID: 2315461 [TBL] [Abstract][Full Text] [Related]
9. Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra. Cole DG; Growdon JH; DiFiglia M Exp Neurol; 1993 Apr; 120(2):223-32. PubMed ID: 8491280 [TBL] [Abstract][Full Text] [Related]
10. L-dopa-induced desensitization depends on 5-hydroxytryptamine imbalance in hemiparkinsonian rats. Kääriäinen TM; García-Horsman JA; Piltonen M; Männistö PT Neuroreport; 2009 Feb; 20(3):313-8. PubMed ID: 19188858 [TBL] [Abstract][Full Text] [Related]
11. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease. Mela F; Marti M; Dekundy A; Danysz W; Morari M; Cenci MA J Neurochem; 2007 Apr; 101(2):483-97. PubMed ID: 17359492 [TBL] [Abstract][Full Text] [Related]
12. Catechol-O-methyltransferase and Parkinson's disease. Reches A; Fahn S Adv Neurol; 1984; 40():171-9. PubMed ID: 6695593 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of DOPA accumulation by rat brain at critical L-DOPA circulating concentrations. Horst WD; Bautz G; Renyi E; Spirt N Adv Neurol; 1974; 5():369-73. PubMed ID: 4440584 [No Abstract] [Full Text] [Related]
14. Favorable effect of catechol-O-methyltransferase inhibition by OR-462 in experimental models of Parkinson's disease. Lindén IB; Nissinen E; Etemadzadeh E; Kaakkola S; Männistö P; Pohto P J Pharmacol Exp Ther; 1988 Oct; 247(1):289-93. PubMed ID: 3171977 [TBL] [Abstract][Full Text] [Related]
15. The effect of L-DOPA on brain polysomes and protein synthesis: probable mediation by intracellular dopamine. Weiss BF; Roel LE; Munro HN; Wurtman RJ Adv Neurol; 1974; 5():87-99. PubMed ID: 4155238 [No Abstract] [Full Text] [Related]
16. Pentobarbital inhibits L-DOPA-induced dopamine increases in the rat striatum: An in vivo microdialysis study. Adachi YU; Yamada S; Satomoto M; Watanabe K; Higuchi H; Kazama T; Doi M; Sato S Brain Res Bull; 2006 May; 69(5):593-6. PubMed ID: 16647588 [TBL] [Abstract][Full Text] [Related]
17. L-DOPA preloading increases the uptake of borophenylalanine in C6 glioma rat model: a new strategy to improve BNCT efficacy. Capuani S; Gili T; Bozzali M; Russo S; Porcari P; Cametti C; D'Amore E; Colasanti M; Venturini G; Maraviglia B; Lazzarino G; Pastore FS Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):562-7. PubMed ID: 18793958 [TBL] [Abstract][Full Text] [Related]
18. [Interaction of L-DOPA and pyridoxine (a review of the literature)]. Uspenskiĭ AE Farmakol Toksikol; 1977; 40(6):722-33. PubMed ID: 340258 [No Abstract] [Full Text] [Related]
19. Effects of L-dopa on epinephrine concentration in rat brain: possible role of inhibition of norepinephrine N-methyltransferase by S-adenosylhomocysteine. Fuller RW; Hemrick-Luecke SK; Perry KW J Pharmacol Exp Ther; 1982 Oct; 223(1):84-9. PubMed ID: 7120131 [TBL] [Abstract][Full Text] [Related]
20. Effect of L-dopa on copper concentrations in the rat brain. Krari N; Allain P Neurotoxicology; 1993; 14(1):81-2. PubMed ID: 8361682 [No Abstract] [Full Text] [Related] [Next] [New Search]